Get the Stockscreener App
24.10
1.26%
0.30
After Hours:
24.09
-0.01
-0.04%
Instil Bio Inc stock is traded at $24.10, with a volume of 207.47K.
It is up +1.26% in the last 24 hours and down -10.18% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$23.80
Open:
$23.37
24h Volume:
207.47K
Relative Volume:
0.96
Market Cap:
$162.69M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-2.1159
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-23.49%
1M Performance:
-10.18%
6M Performance:
+33.22%
1Y Performance:
-48.13%
1-Day Range:
$23.37
$25.50
1-Week Range:
$22.67
$30.50
52-Week Range:
$10.80
$92.00
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
24.10 | 155.13M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
Will breakout in Instil Bio Inc. lead to full recoveryJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Predicting Instil Bio Inc. trend using moving averages2025 Investor Takeaways & Weekly High Momentum Picks - Newser
Applying Elliott Wave Theory to Instil Bio Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - Newser
News impact scoring models applied to Instil Bio Inc.July 2025 Short Interest & Risk Controlled Swing Alerts - Newser
How to build a dashboard for Instil Bio Inc. stock2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Risk adjusted return profile for Instil Bio Inc. analyzedMarket Activity Report & Fast Moving Stock Watchlists - Newser
What data driven models say about Instil Bio Inc.’s futureGap Up & Fast Entry Momentum Trade Alerts - Newser
What institutional flow reveals about Instil Bio Inc.Market Performance Report & Technical Pattern Recognition Alerts - Newser
Instil Bio stock rating reiterated at Buy by H.C. Wainwright - Investing.com
Will Instil Bio Inc. stock recover after recent dropGold Moves & Real-Time Price Movement Reports - Newser
Strategies to average down on Instil Bio Inc.Quarterly Profit Review & Long-Term Growth Stock Strategies - Newser
Using data models to predict Instil Bio Inc. stock movementStop Loss & High Accuracy Swing Entry Alerts - Newser
Can volume confirm reversal in Instil Bio Inc.2025 Volume Leaders & Weekly Stock Performance Updates - Newser
Can trapped investors hope for a rebound in Instil Bio Inc.Wall Street Watch & Long-Term Capital Growth Strategies - Newser
Is Instil Bio Inc. stock poised for growthQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - Newser
Will earnings trigger a reversal in Instil Bio Inc.Bond Market & Reliable Price Breakout Signals - Newser
Order flow analysis tools used on Instil Bio Inc.July 2025 Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Should you hold or exit Instil Bio Inc. now2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Risk vs reward if holding onto Instil Bio Inc.Market Performance Recap & Technical Confirmation Trade Alerts - Newser
Price action breakdown for Instil Bio Inc.2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 - GlobeNewswire
35% Treatment Response: Instil Bio's Novel Cancer Drug Shows Promise in Advanced Lung Cancer Patients - Stock Titan
Combining machine learning predictions for Instil Bio Inc.2025 Major Catalysts & Real-Time Price Movement Reports - Newser
Real time breakdown of Instil Bio Inc. stock performanceEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Identifying reversal signals in Instil Bio Inc.IPO Watch & Risk Managed Investment Signals - Newser
How to interpret RSI for Instil Bio Inc. stockJuly 2025 Market Mood & Low Risk High Reward Trade Ideas - Newser
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):